These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 825277)

  • 21. Rapid assay for von Willebrand factor activity using formalin-fixed platelets and microtitration technic.
    Ramsey R; Evatt BL
    Am J Clin Pathol; 1979 Dec; 72(6):996-9. PubMed ID: 316281
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Electroblotting of factor VIII/von Willebrand factor multimers after electrophoresis in SDS-agarose gel, discontinuous buffer system.
    Batlle J; López Fernández MF; López Berges C; López Borrasca A
    Br J Haematol; 1983 Sep; 55(1):195-6. PubMed ID: 6411111
    [No Abstract]   [Full Text] [Related]  

  • 23. An immunoradiometric assay for human factor VIII/von Willebrand factor (VIII:vWF) using a monoclonal antibody that defines a functional epitope.
    Goodall AH; Jarvis J; Chand S; Rawlings E; O'Brien DP; McGraw A; Hutton R; Tuddenham EG
    Br J Haematol; 1985 Apr; 59(4):565-77. PubMed ID: 2580547
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immunoradiometric assays for factor VIII antigens: coagulant protein (antihemophilic factor) and factor VIII-related protein (von Willebrand factor).
    Hoyer LW; Trabold NC
    Methods Enzymol; 1982; 84():51-60. PubMed ID: 6808318
    [No Abstract]   [Full Text] [Related]  

  • 25. Factor VIII-von Willebrand factor in giant cell arteritis and polymyalgia rheumatica.
    Persellin ST; Daniels TM; Rings LJ; Kazmier FJ; Bowie EJ; Hunder GG
    Mayo Clin Proc; 1985 Jul; 60(7):457-62. PubMed ID: 3925247
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Pathophysiology of von Willebrand's disease: Qualitative and quantitative analysis of von Willebrand protein.
    Fukui H; Yoshioka A; Mikami S; Takase T; Fujimura Y; Takahashi Y; Nishino M; Iwagaki K
    Nihon Ketsueki Gakkai Zasshi; 1979 Dec; 42(6):839-50. PubMed ID: 121660
    [No Abstract]   [Full Text] [Related]  

  • 27. Influence of high ionic strength buffers on factor VIII/von Willebrand factor from different species.
    Lavergne JM; Meyer D; Jenkins CS; Obert B; Larrieu MJ
    Thromb Res; 1978 Sep; 13(3):409-18. PubMed ID: 311086
    [No Abstract]   [Full Text] [Related]  

  • 28. Plasma and platelet von Willebrand factor defects in uremia.
    Gralnick HR; McKeown LP; Williams SB; Shafer BC; Pierce L
    Am J Med; 1988 Dec; 85(6):806-10. PubMed ID: 3264111
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of proteases in AHF concentrates: effect on factor VIII:von Willebrand protein as assessed by high-pressure gel permeation chromatography.
    Orthner CL
    J Lab Clin Med; 1984 Nov; 104(5):816-28. PubMed ID: 6436416
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Value of factor VIII related antigen as a means of demonstrating extramedullary haemopoiesis.
    Crocker J; Smith PJ
    J Clin Pathol; 1985 Mar; 38(3):355. PubMed ID: 3919067
    [No Abstract]   [Full Text] [Related]  

  • 31. The in vitro association of antihemophilic factor and von Willebrand factor.
    Zucker MB; Soberano ME; Johnson AJ; Fulton AJ; Kowalski S; Adler M
    Thromb Haemost; 1983 Feb; 49(1):37-41. PubMed ID: 6405497
    [No Abstract]   [Full Text] [Related]  

  • 32. Elevated fibrinogen, von Willebrand factor, and Factor VIII confer resistance to dilutional coagulopathy and activated protein C in normal pregnant women.
    Tanaka KA; Bharadwaj S; Hasan S; Judd M; Abuelkasem E; Henderson RA; Chow JH; Williams B; Mazzeffi MA; Crimmins SD; Malinow AM
    Br J Anaesth; 2019 Jun; 122(6):751-759. PubMed ID: 30916034
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Abnormal plasma levels of factor VIII/von Willebrand factor complex in myocardial infarction--expression of acute phase reaction or index of vascular endothelium damage?
    Giustolisi R; Musso R; Cacciola E; Cacciola RR; Russo M; Petralito A
    Thromb Haemost; 1984 Jul; 51(3):408. PubMed ID: 6437008
    [No Abstract]   [Full Text] [Related]  

  • 34. [Multimeric structure of factor VIII/von Willebrand factor released from human platelets by ADP, collagen and thrombin].
    López Fernández MF; Batlle Fonrodona FJ; Ginsberg MH; Ruggeri ZM; Zimmerman TS
    Sangre (Barc); 1983; 28(4):439-49. PubMed ID: 6419355
    [No Abstract]   [Full Text] [Related]  

  • 35. The nature of the interaction between ristocetin-Willebrand factor VIII coagulant activity molecule.
    Brockway WJ; Fass DN
    J Lab Clin Med; 1977 Jun; 89(6):1295-1305. PubMed ID: 16975
    [No Abstract]   [Full Text] [Related]  

  • 36. Willebrand factor in von Willebrand's disease.
    Boulton FE; Lloyd MJ
    Br Med J; 1975 Nov; 4(5993):384. PubMed ID: 1081419
    [No Abstract]   [Full Text] [Related]  

  • 37. Platelet von Willebrand factor: comparison with plasma von Willebrand factor.
    Gralnick HR; Williams SB; McKeown LP; Krizek DM; Shafer BC; Rick ME
    Thromb Res; 1985 Jun; 38(6):623-33. PubMed ID: 3927508
    [TBL] [Abstract][Full Text] [Related]  

  • 38. On von Willebrand's disease (vWd).
    Firkin BG; Howard MA
    Br J Haematol; 1976 Feb; 32(2):151-8. PubMed ID: 1082345
    [No Abstract]   [Full Text] [Related]  

  • 39. Carbohydrate deficiency of the factor VIII/von Willebrand factor Protein in von Willebrand's disease variants.
    Gralnick HR; Coller BS; Sultan Y
    Science; 1976 Apr; 192(4234):56-9. PubMed ID: 1083071
    [TBL] [Abstract][Full Text] [Related]  

  • 40. An improvemed assay for von Willebrand factor.
    Head DR; Bowman RP; Marmer DJ; Brossoit AD
    Am J Clin Pathol; 1979 Dec; 72(6):991-5. PubMed ID: 117698
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.